incorrect again it’s how the phase 1 study was designed. Not one presentation or announcement has indicated that this design was for multiple conditions as each condition needs a different dose timing and concentration.
incorrect again it’s how the phase 1 study was designed. Not one...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.0¢ |
Change
-0.010(1.33%) |
Mkt cap ! $94.78M | |||
| Open | High | Low | Value | Volume |
| 75.0¢ | 76.0¢ | 74.0¢ | $35.74K | 47.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 540 | 74.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 39562 | 2 |
View Market Depth
| Last trade - 15.59pm 17/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |